Senator Cruz Letter to the FDA

Ted Cruz Letter to FDA Says Hydroxychloroquine Restrictions May Be ‘Directly Costing Lives’

On Tuesday, Sen. Ted Cruz (R-TX) co-authored a letter to Commissioner Stephen Hahn of the U.S. Food and Drug Administration (FDA) calling out the agency and requesting more information regarding its revocation of the Emergency Use Authorization (EAU) for hydroxychloroquine and chloroquine in treating COVID-19.

U.S. Sens. Ron Johnson (R-WI) and Mike Lee (R-UT) also signed the letter.

The document cites licensed physicians who have said that the federal government’s EUA revocation has resulted in state agencies attempting to quash the off-label use of the drug.

While the letter does not list specific physicians, several practicing medical doctors recently promoted the use of hydroxychloroquine and expressed similar concerns in a town hall meeting hosted by state Sen. Bob Hall (R-Edgewood).